Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Your ultimate guide to the 2024 North Carolina State Fair
Recommended
North Carolina Voter Guide 2024: Who's running, how, where, when to vote in NC election
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biora Therapeutics, Inc. - Common Stock
(NQ:
BIOR
)
4.300
+3.746 (+676.45%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biora Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Biora Therapeutics Announces $9.75 Million Direct Offering
November 07, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Sale of Cell-Free DNA Patent Rights
October 27, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients
October 25, 2022
Data Presented at the ACG Annual Meeting Demonstrates Successful Detection of Colon Entry and Topical Coverage Throughout Portion of Colon Implicated in Patients with Active Ulcerative Colitis
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Recap: Biora Therapeutics Q2 Earnings
August 15, 2022
Biora Therapeutics (NASDAQ:BIOR) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Biora Therapeutics Shares Five Posters Presented at American College of Gastroenterology Annual Scientific Meeting 2022
October 24, 2022
Presents Results on Device Performance Studies in Humans for Targeted Therapeutics Platform
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference
October 19, 2022
Further Demonstrating Possibilities for Systemic Delivery of Large Molecules
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Participate in 12th Annual Partnership Opportunities in Drug Delivery Conference
October 10, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
October 04, 2022
On Tuesday, 44 companies hit new 52-week lows.
Via
Benzinga
Why Twin Vee Powercats Is Trading Lower By Over 30%; Here Are 30 Stocks Moving Premarket
September 29, 2022
Gainers Windtree Therapeutics, Inc (NASDAQ: WINT) rose 50.7% to $0.4827 in pre-market trading after the company said Istaroxime Phase 2 study in early cardiogenic shock was published in the European...
Via
Benzinga
Biora Therapeutics's Return on Invested Capital Insights
September 12, 2022
According to Benzinga Pro data, during Q2, Biora Therapeutics (NASDAQ:BIOR) posted sales of $104 thousand. Earnings were up 60.07%, but Biora Therapeutics still reported an overall loss of $5.51...
Via
Benzinga
Biora Therapeutics Earnings: A Preview
August 12, 2022
Biora Therapeutics (NASDAQ:BIOR) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 10, 2022
Via
Benzinga
Biora Therapeutics to Participate in Upcoming BTIG Investment Conference
July 26, 2022
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 10, 2022
Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their outstanding shares is at $47.8 million.
Via
Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
Via
Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
August 11, 2022
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.
Via
Benzinga
Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session
August 10, 2022
Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380.
Via
Benzinga
PLTR Stock Falls Another 5% as RBC Downgrades Palantir
May 10, 2022
Palantir Technologies (PLTR) stock is slipping on Tuesday as investors react to a downgrade for the shares from RBC Capital Markets.
Via
InvestorPlace
Why Is GoodRx (GDRX) Stock Down Today?
May 10, 2022
GoodRx (GDRX) stock is slipping on Tuesday despite the healthcare company beating out estimates for the first quarter of 2022.
Via
InvestorPlace
BIOR Stock Starts Trading as Progenity’s Rebrand Takes Shape. What to Know.
May 10, 2022
Biora's product is supposed to enable biologics to be delivered directly to GI tracts. BIOR stock is a favorite of retail investors.
Via
InvestorPlace
30 Stocks Moving in Tuesday's Pre-Market Session
May 10, 2022
Gainers Vroom, Inc. (NASDAQ: VRM) shares rose 38% to $1.49 in pre-market trading after the company reported better-than-expected Q1 results.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.